Healthpeak Properties, Inc.
Healthpeak Properties (DOC) is a healthcare real estate investment trust (REIT) focused on life science and medical office buildings, with a primary political signal of zero direct federal lobbying or contract exposure but active congressional trading by three members.
BusinessWhat DOC does
Healthpeak Properties operates as a real estate investment trust (REIT) specializing in the ownership, development, and management of healthcare-related real estate. Its portfolio is concentrated in life science facilities and medical office buildings, generating revenue primarily through long-term leases to tenants in the healthcare and biopharmaceutical sectors. The company's market cap is approximately $11.8 billion.
12 months past · 3 months futureDOC activity timeline
Executive Branch ConflictsDOC held by Trump-administration officials
Lifetime Government AwardsDOC federal contracts
DOC doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding DOC
Politicians Trading DOCMembers of Congress with recent DOC positions
Congressional TradesWho in Congress is trading DOC
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting DOCLive legislation impacting this stock
Political ProfileWhere DOC sits in Washington
[object Object]
STRUCTURAL: No direct federal contract history (`get_government_precedent.federal_contracts_summary` is null), zero lobbying spend (`get_political_influence.lobbying.total_income` is 0), and no executive branch holdings (`get_executive_branch_exposure.totals.total_positions_matched` is 0). EVIDENTIARY: Three congressional traders (bioguide_ids C001123, M001136, B001327) executed 8 transactions in the last 12 months (`Top congressional traders`), and 10 corporate insider purchases totaling ~$1.02M occurred in Q2 2025 (`Recent corp insider Form 4 buys`). Net: Evidentiary buying is offset by a complete lack of structural political engagement.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Broad financial sector legislative riskU.S. Congress"Eight recent finance-sector bills in `Recent bill_impacts` show uniform, low-impact exposure (impact_ratio 0.0002 each)."
Regulatory opportunities
- No specific regulatory opportunities flagged.
Live signals + predictions for DOC — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades DOC
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord